Accession Number:

ADA591862

Title:

Acinetobacter Species Infections among Navy and Marine Corps Beneficiaries: 2012 Annual Report

Descriptive Note:

Technical rept. Jan 2005-Dec 2012

Corporate Author:

NAVY AND MARINE CORPS PUBLIC HEALTH CENTER PORTSMOUTH VA

Personal Author(s):

Report Date:

2013-11-18

Pagination or Media Count:

36.0

Abstract:

The EpiData Center Department EDC at the Navy and Marine Corps Public Health Center NMCPHC conducts routine surveillance of clinically significant organisms within the Department of the Navy DON as well as the Department of Defense DOD. This report provides a summary of Acinetobacter species isolates in calendar year CY 2012 and describes the demographics, clinical characteristics, prescription practices, and antibiotic resistance patterns observed among all DOD beneficiaries as well as active duty DON service members and recruits. Acinetobacter species are associated with a large number of infections, have the ability to easily acquire resistance determinants, and quickly develop resistance to multiple antibiotics, leaving few, if any, treatment options. In calendar year CY 2012, the overall Acinetobacter infection rate was 5.3 per 100,000 beneficiaries in the Department of the Navy DON and 4.8 per 100,000 beneficiaries in the Department of Defense DOD both rates decreased from previous years. Acinetobacter among DON beneficiaries was most frequently identified in the outpatient setting 76.7, from non-sterile body sites 61.3, and among 18-24 year olds 36.0. The most common species identified was A. baumannii 42.7. For MDRXDR cases, providers most commonly prescribed vancomycin, meropenem, or doxycycline. Cases with susceptibility testing results showed that, among DON beneficiaries, organisms were most susceptible to gentamicin 92.4, followed by imipenem 91.2, and levofloxacin 90.0 organisms were least susceptible to ampicillin 7.0. This report could help infection preventionists and infectious disease practitioners make informed decisions on the treatment of Acinetobacter infections. In addition, this report monitors antibiotic resistance in this organism. Understanding the current disease dynamics will help ensure military health providers have the best information possible, thus ensuring quality care and missi

Subject Categories:

  • Medicine and Medical Research
  • Microbiology
  • Pharmacology
  • Military Forces and Organizations

Distribution Statement:

APPROVED FOR PUBLIC RELEASE